Clinical Trials Logo

Filter by:
NCT ID: NCT01951443 Completed - Clinical trials for Arterial Stiffness, Blood Pressure

Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure

KRAB
Start date: August 2013
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the acute effect of a standardized extract of KRG (Rg3-KRG) consisting of 30% total ginsenosides, including 10% Rg3 ginsenoside on arterial stiffness and blood pressure, as measured by the following parameters: aortic augmentation index, peripheral blood pressure, central blood pressure

NCT ID: NCT01951326 Completed - Crohn's Disease Clinical Trials

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

MAPUS
Start date: September 2013
Phase: Phase 3
Study type: Interventional

The investigators hypothesize that RHB-104 will have greater efficacy than placebo in Crohn's disease.

NCT ID: NCT01950637 Completed - Clinical trials for Diabetes Mellitus, Type 2

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

Start date: January 2012
Phase: N/A
Study type: Observational

This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.

NCT ID: NCT01950598 Completed - Corneal Blindness Clinical Trials

Frozen Versus Fresh Corneal Carriers for the Boston KPro Type I Donor Carriers

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether frozen corneas are as safe and effective as fresh corneas for use as carriers with the Boston Keratoprosthesis type I (KPro) over long term follow-up. Corneal transplantation is typically performed using fresh, transparent corneas. With KPro surgery, the corneal transplant only serves as a carrier to suture the KPro in place. The cornea used in KPro surgery does not need to be clear like a normal transplant. Frozen corneal tissue can be used to repair the cornea in cases of emergency but the tissue is not transparent and does not allow good vision. We hypothesize that frozen grafts are equivalent as fresh grafts when used as carrier for the KPro.

NCT ID: NCT01950442 Completed - Esophageal Cancer Clinical Trials

Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer

CT0046
Start date: October 2013
Phase: N/A
Study type: Interventional

Despite improvement in treatment-related morbidity and mortality, esophageal cancer is still one of the most lethal malignancies. Accurate staging is essential to establish prognosis and for patient management. Staging helps to determine if surgery, chemotherapy, radiation therapy, a combination of these, or a palliative approach is the most appropriate. Endoscopic ultrasound techniques are becoming more and more popular. At Notre Dame Hospital, Centre Hospitalier de L'Universite de Montreal, all patients diagnosed with esophageal cancer undergo complete EUS staging. In selected patients, EUS is followed by EBUS during the same procedure, in order to examine all the lymph nodes near or far from the primary tumor amenable to EBUS guided trans-bronchial biopsy. In patients with a malignant esophageal stricture, we have preformed very gentle balloon dilation up to 14 mm. It is important to realize that this is not to achieve symptom resolution, but rather to allow the passage of the scope. We hypothesize that earlier reports of higher perforation rates were related to unnecessary aggressive dilation. Thus far, we have successfully dilated over 60 patients during the last four years (2009-2013) and were able to pass the scope and complete the examination in the vast majority of patients with no morbidity.

NCT ID: NCT01949935 Completed - Clinical trials for Surgical Site Infections

Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting

MIR-CABG
Start date: March 2009
Phase: Phase 3
Study type: Interventional

The hypothesis is that application of Mupirocin to the nose before and after coronary artery bypass grafting surgery will reduce the incidence of surgical site infections.

NCT ID: NCT01949727 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2)

Start date: October 2013
Phase:
Study type: Observational

Chronic obstructive pulmonary disease (COPD) is a chronic lung disease primarily caused by smoking. COPD creates a tremendous burden to the healthcare system, as disease exacerbations result in frequent, prolonged hospitalizations. While originally considered a disease specific to the lung, data have shown that COPD is associated with substantial cardiovascular (CV) morbidity and mortality. Exacerbations of COPD requiring hospitalization result in marked patient deterioration, and heightened CV risk. The cause of the increased CV risk with stable COPD, and the exaggerated CV risk during exacerbations of the disease are unknown; however, it may be due to chronic inflammation which is exacerbated with a flare-up of the disease, and/or chronic inactivity which is similarly worsened with bed-rest during a hospitalization. Despite the impact of COPD on healthcare, there are relatively few studies examining how COPD inpatient care impacts on patient outcomes, inflammation and CV risk. Disease management programs, such as pulmonary rehabilitation and patient self-management education, are part of guideline therapy for COPD; however, these are not regularly implemented following a hospitalization, and how these interventions affect patient outcomes, behavior, physical activity, inflammation and CV risk have not been well studied. The proposed long-term project will examine how typical inpatient COPD care, and how early referral to chronic disease management programs after hospital discharge, affect patient outcomes. This grant brings together an outstanding group of researchers who have the necessary clinical, content and methodological expertise to successfully complete this work. These studies will provide invaluable information about inpatient and outpatient management for a disease which has a tremendous impact on healthcare.

NCT ID: NCT01949532 Completed - Clinical trials for End-stage Renal Disease

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

Start date: January 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to see how the body and the cancer react to carfilzomib, including measuring the amount of the study drug in the blood at certain times following dosing. This study is being done in people with normal kidney function and those with end-stage renal disease to see if they respond differently to the study drug.

NCT ID: NCT01949441 Completed - Rhinoconjunctivitis Clinical Trials

ToleroMune House Dust Mite (HDM) Tolerability Study

Start date: September 2013
Phase: Phase 2
Study type: Interventional

House Dust Mites (HDMs) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDMA in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients. ToleroMune House Dust Mite (TM-HDM), a combination of seven Synthetic Peptide Immuno-Regulatory Epitopes, is being developed for the treatment of HDM allergy. This study to assess the tolerability of ToleroMune House Dust Mite in subjects with controlled asthma and house dust mite-induced rhinoconjunctivitis.

NCT ID: NCT01949428 Completed - Rhinoconjunctivitis Clinical Trials

House Dust Mite Observational Study

Start date: September 2013
Phase: N/A
Study type: Observational

A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis